| With 2005 actual spending of $7.4 billion, Pfizer Global Research and Development (PGRD) is the world's largest privately funded biomedical research organization. PGRD is headquartered in New London, CT and has major facilities in Groton, CT; Cambridge, MA; Ann Arbor and Kalamazoo, MI; St. Louis, MO; LaJolla, CA; Sandwich, UK and Nagoya, Japan. PGRD employs more than 13,000 colleagues worldwide. Pfizer's search for new treatments spans hundreds of research projects across 11 therapeutic areas. Our scientists, clinicians, technicians, and other professionals employ state-of-the-art tools ranging from robotic high-throughput screening (a method pioneered by Pfizer) to sophisticated genomic studies, to deliver a steady stream of innovative new products that enhance human and animal health. PGRD has links with more than 250 partners in academia and industry to strengthen its position on the cutting edge of science and biotechnology. Pfizer conducts research and development across 11 therapeutic areas: - Allergy & Respiratory
- Cardiovascular, Metabolic & Endocrine Diseases
- Central Nervous System Disorders
- Dermatology
- Gastrointestinal Diseases
- Infectious Diseases
- Inflammation
- Oncology
- Ophthalmology
- Pain
- Sexual Health & Urogenital Disorders
|  |